Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

High-Sensitivity Terahertz Refractive Index Sensor Using Black Phosphorus-MXene-Graphene Hybrid Metasurfaces for Label-Free COVID-19 Detection
Jacob Wekalao, Refka Ghodhbani, R. Dhivya, et al.
Plasmonics (2025)
Closed Access | Times Cited: 2
Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
Ling Ye, Shicheng Fan, Pengfei Zhao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 9, pp. 3598-3637
Open Access | Times Cited: 28
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study
Yuta Matsubara, Hiroki Kiyohara, Yohei Mikami, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 3, pp. 195-208
Closed Access | Times Cited: 6
Changes in symptoms and characteristics of COVID-19 patients across different variants: two years study using neural network analysis
Seyed Hossein Torabi, Seyed Mohammad Riahi, Azadeh Ebrahimzadeh, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Impact of COVID-19 vaccination status on hospitalization and disease severity: A descriptive study in Nagasaki Prefecture, Japan
Guoxi Cai, Shiwen Liu, Yixiao Lu, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Antidiabetic agent use and clinical outcomes in patients with diabetes hospitalized for COVID-19: a systematic review and meta-analysis
Jordan N. Keels, Isabella R. McDonald, Christopher S. Lee, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Outcomes of COVID-19 in the Omicron-predominant wave: large-scale real-world data analysis with a comparison to influenza
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, et al.
Pneumonia (2025) Vol. 17, Iss. 1
Open Access
CLINICAL CHARACTERISTICS OF PATIENTS WITH COMMUNITY-ACQUIRED CORONAVIRUS ASSOCIATED PNEUMONIA
S. Ya. Dotsenko, O. S. Kulbachuk, O.V. Soloviov
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії (2025) Vol. 25, Iss. 1, pp. 24-28
Open Access
Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study
Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights
Heng Joo Ng, Maaz Kamal Alata, Quang The Nguyen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Mortality and COVID Infection: Predictors of Mortality 10 Months after Discharge
Víctor Eugenio Vera-Delgado, Dácil García-Rosado, Onán Pérez‐Hernández, et al.
Diseases (2024) Vol. 12, Iss. 6, pp. 123-123
Open Access | Times Cited: 1
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome
Kentaro Nakashima, Takashi Imai, Akira Shiraishi, et al.
Clinical & Experimental Immunology (2024) Vol. 217, Iss. 3, pp. 291-299
Closed Access | Times Cited: 1
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study
Susin Park, Nam Kyung Je, Dong Wan Kim, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Features of the covid-19 epidemic and characteristics of patients during the spread of the delta SARS-COV-2 in Russia
A. A. Fomicheva, Nikolay Pimenov, S. V. Komarova, et al.
Journal Infectology (2024) Vol. 16, Iss. 4, pp. 45-55
Open Access | Times Cited: 1
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan
Kohei Ishiga, Hiromichi Wakui, Kengo Azushima, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients with Different Variants of SARS-CoV-2 in a Tertiary Care Hospital, Thailand
Kitchawan Hengkrawit, Juthamas Thananon, Kritakarn Telapol, et al.
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 11, pp. 266-266
Open Access | Times Cited: 1
Prevalence and characteristics of newly diagnosed heart failure in patients with shortness of breath after coronavirus infection
O. V. Masalkina, Н. А. Козиолова, N. M. Syuzeva
Russian Journal of Cardiology (2023) Vol. 28, Iss. 3, pp. 5385-5385
Open Access | Times Cited: 2
Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
F1000Research (2023) Vol. 12, pp. 398-398
Open Access | Times Cited: 2
Development and validation of a prediction model based on comorbidities to estimate the risk of in-hospital death in patients with COVID-19
Yangjie Zhu, Boyang Yu, Kang Tang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Prevalence of depressive symptoms and correlates among individuals who self-reported SARS-CoV-2 infection after optimizing the COVID-19 response in China
Liangjia Wei, Jiao Qin, Zhifeng Lin, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access
Drug effectiveness for COVID-19 inpatients inferred from Japanese medical claim data using propensity score matching
Shingo Mitsushima, Hiromasa Horiguchi, Kiyosu Taniguchi
F1000Research (2024) Vol. 12, pp. 398-398
Open Access
Machine Learning-Driven Prediction of ICU Admissions for COVID-19 Patients
A. M. Mutawa
(2024)
Open Access
Medical resource usage for COVID-19 evaluated using the National Database of Health Insurance Claims and Specific Health Checkups of Japan
Keita Fukuyama, Yukiko Mori, Hiroaki Ueshima, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303493-e0303493
Open Access
Clinical and epidemiological risk factors associated with hospitalization and mortality rate of COVID-19 patients in Banja Luka County: A retrospective observational cohort study on 40,000 patients
Natasa Pilipovic Broceta, Nevena Todorović, Ranko Škrbić, et al.
Journal of Family Medicine and Primary Care (2024) Vol. 13, Iss. 5, pp. 2130-2137
Open Access
Prognostic value of interleukin‐6 serum levels in hospitalized COVID‐19 patients: A case—control study in Iran
Asiyeh Shojaee, Reza Rafiee, Massood Hosseinzadeh, et al.
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access
Page 1 - Next Page

Scroll to top